Revenue Breakdown
Composition ()
No data
Revenue Streams
Dexcom Inc (DXCM) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Distributor, accounting for 84.8% of total sales, equivalent to $1.03B. Another important revenue stream is Direct. Understanding this composition is critical for investors evaluating how DXCM navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Dexcom Inc maintains a gross margin of 70.30%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 33.01%, while the net margin is 21.22%. These profitability ratios, combined with a Return on Equity (ROE) of 34.50%, provide a clear picture of how effectively DXCM converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, DXCM competes directly with industry leaders such as MTD and PHG. With a market capitalization of $28.40B, it holds a significant position in the sector. When comparing efficiency, DXCM's gross margin of 70.30% stands against MTD's 58.05% and PHG's 44.88%. Such benchmarking helps identify whether Dexcom Inc is trading at a premium or discount relative to its financial performance.
